These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18390864)

  • 1. Use of human spironolactone in dogs with heart failure.
    Broadfoot F; McGuire P
    Vet Rec; 2008 Apr; 162(14):460. PubMed ID: 18390864
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of human spironolactone in dogs with heart failure.
    Watson P
    Vet Rec; 2008 May; 162(18):599. PubMed ID: 18453386
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of human spironolactone in dogs with heart failure.
    Whitehead M
    Vet Rec; 2008 May; 162(18):599. PubMed ID: 18453385
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of efficacy of low-dose spironolactone as adjunct treatment to conventional congestive heart failure treatment in dogs.
    Schuller S; Van Israël N; Vanbelle S; Clercx C; McEntee K
    J Vet Pharmacol Ther; 2011 Aug; 34(4):322-31. PubMed ID: 20950346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of spironolactone in dogs with chronic heart failure because of degenerative valvular disease: a population-based, longitudinal study.
    Lefebvre HP; Ollivier E; Atkins CE; Combes B; Concordet D; Kaltsatos V; Baduel L
    J Vet Intern Med; 2013; 27(5):1083-91. PubMed ID: 23869534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease.
    Kittleson MD; Bonagura JD
    J Vet Intern Med; 2010; 24(6):1245-6; author reply 1247-8. PubMed ID: 21054535
    [No Abstract]   [Full Text] [Related]  

  • 7. Digitalis versus diuretics: an individualized approach.
    Wood GL
    Vet Clin North Am; 1978 May; 8(2):245-56. PubMed ID: 685068
    [No Abstract]   [Full Text] [Related]  

  • 8. Aldosterone receptor antagonists--how cardiovascular actions may explain their beneficial effects in heart failure.
    Ovaert P; Elliott J; Bernay F; Guillot E; Bardon T
    J Vet Pharmacol Ther; 2010 Apr; 33(2):109-17. PubMed ID: 20444035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the loop diuretic torsemide in three dogs with advanced heart failure.
    Oyama MA; Peddle GD; Reynolds CA; Singletary GE
    J Vet Cardiol; 2011 Dec; 13(4):287-92. PubMed ID: 22030290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preclinical pharmacokinetic and pharmacodynamic approach to determine a dose of spironolactone for treatment of congestive heart failure in dog.
    Guyonnet J; Elliott J; Kaltsatos V
    J Vet Pharmacol Ther; 2010 Jun; 33(3):260-7. PubMed ID: 20557443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New hope from a 40-year-old drug: deaths from heart failure cut by 30 percent.
    Comarow A
    US News World Rep; 1999 Aug; 127(5):69. PubMed ID: 10539698
    [No Abstract]   [Full Text] [Related]  

  • 12. Congestive heart failure in dogs: therapeutic concepts.
    Detweiler DK; Knight DH
    J Am Vet Med Assoc; 1977 Jul; 171(1):106-14. PubMed ID: 328463
    [No Abstract]   [Full Text] [Related]  

  • 13. Left-sided congestive heart failure in dogs: treatment and monitoring of emergency patients.
    Erling P; Mazzaferro EM
    Compend Contin Educ Vet; 2008 Feb; 30(2):94-104. PubMed ID: 18368691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of combined angiotensin-converting enzyme inhibitors and spironolactone on serum K+, Mg 2+, and Na+ concentrations in small dogs with degenerative mitral valve disease.
    Thomason JD; Rockwell JE; Fallaw TK; Calvert CA
    J Vet Cardiol; 2007 Nov; 9(2):103-8. PubMed ID: 17983885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SEISICAT study: a pilot study assessing efficacy and safety of spironolactone in cats with congestive heart failure secondary to cardiomyopathy.
    James R; Guillot E; Garelli-Paar C; Huxley J; Grassi V; Cobb M
    J Vet Cardiol; 2018 Feb; 20(1):1-12. PubMed ID: 29277469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease.
    Bernay F; Bland JM; Häggström J; Baduel L; Combes B; Lopez A; Kaltsatos V
    J Vet Intern Med; 2010; 24(2):331-41. PubMed ID: 20102506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spironolactone for heart failure: spiraling out of control.
    Geraci JM; Knowlton AA
    Chest; 2000 Dec; 118(6):1522-3. PubMed ID: 11115427
    [No Abstract]   [Full Text] [Related]  

  • 18. Spironolactone in the management of congestive heart failure.
    Muller JE
    Am J Cardiol; 1990 Jun; 65(23):51K-53K. PubMed ID: 2353671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spironolactone and congestive heart-failure.
    Georges B; Beguin C; Jadoul M
    Lancet; 2000 Apr; 355(9212):1369-70. PubMed ID: 10776778
    [No Abstract]   [Full Text] [Related]  

  • 20. Spironolactone in heart failure--a revived role for an old drug.
    Bradley C
    Intensive Crit Care Nurs; 2000 Dec; 16(6):403-4. PubMed ID: 11091472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.